Status:
COMPLETED
Prognosis of SRD Patients in the ICU
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
Groupe Hospitalier Pitie-Salpetriere
Sorbonne University
Conditions:
Systemic Rheumatic Diseases
Intensive Care Unit
Eligibility:
All Genders
18-100 years
Brief Summary
Critically ill systemic rheumatic disease (SRD) patients have benefited from better provision of rheumatic and critical care in recent years. Recent comprehensive data regarding in-hospital mortality ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- All consecutive SRD patients admitted to ICUs during the study period
- at least one urine sample
- Exclusion criteria:
- Age \< 18 years
- Persons under protection
- Paritcipation rejections
- Admition to the ICU after scheduled surgery or trauma or suicide attempt unrelated to neurological involvement of SRD
- Cancer treated with chemotherapy within a month before ICU admission
Exclusion
Key Trial Info
Start Date :
March 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2019
Estimated Enrollment :
525 Patients enrolled
Trial Details
Trial ID
NCT04398381
Start Date
March 1 2017
End Date
June 30 2019
Last Update
May 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295